| Incyte Biosciences International Sàrl - Opzelura 15 mg/g, crème | | 69443 | | 01 | | Opzelura 15 mg/g | | crème | | D11AH09 | | | | 30.01.2025 | | |
| | Composition | | ruxolitinibum 15 mg ut ruxolitinibi phosphas, propylenglycolum 150 mg, E 218 1 mg, propylis parahydroxybenzoas 0.5 mg, xanthani gummi, paraffinum liquidum, glyceroli monopalmitostearas, polysorbatum 20, vaselinum album, E 321 1.4 µg, alcohol cetylicus 30 mg, alcohol stearylicus 17.5 mg, dimeticonum 350, triglycerida media, aqua purificata, dinatrii edetas, macrogolum 200, phenoxyethanolum, ad unguentum pro 1 g. | | Packungsbestandteile | | Crème | | | | Principe actif | Concentr. |
|---|
| Ruxolitinibum | 15 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Ad Unguentum | 1 g | | | Alcohol Cetylicus | 30 mg | | | Alcohol Stearylicus | 17.5 mg | | | Aqua Purificata | | | | Dimeticone | 350 | | | Dinatrii Edetas | | | | E 218 | 1 mg | conserv. | | E 321 | 1.4 µg | conserv. | | Glyceroli Monopalmitostearas | | | | Macrogol | 200 | | | Paraffine Liquide | | | | Phénoxyéthanol | | | | Polysorbatum 20 | | | | Propylenglycol | 150 mg | | | Propylis Parahydroxybenzoas | 0.5 mg | | | Triglycerida Media | | | | Vaselinum Album | | | | Xanthani Gummi | | |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 100 g | DDP | DDP | B | | Non | | 002 | 100 g | DDP | DDP | B | | Non |
|
|
